21-360 Efavirenz Clinical Pharmacology Biopharmaceutics Review
Home
/
Documents
Post on 16-Jan-2017
229 views
4 download
Preview:
Click to see full reader
Report this document
SHARE
transcript
Page 1
Page 2
Page 3
Page 4
Page 5
Page 6
Page 7
Page 8
Page 9
Page 10
Page 11
Page 12
Page 13
Page 14
Page 15
Page 16
Page 17
Page 18
Page 19
Page 20
Page 21
Page 22
Page 23
Page 24
Page 25
Page 26
Page 27
Page 28
Page 29
Page 30
Top related
21-434 Xanax Clinical Pharmacology Biopharmaceutics Review … · 2009. 4. 21. · Title: 21-434 Xanax Clinical Pharmacology Biopharmaceutics Review Part 2 Created Date: 11/15/2004
Documents
Regulatory Bases for Clinical Pharmacology and Biopharmaceutics Information in a New Drug Application
Documents
205858Orig1s000 - Food and Drug Administration...205858Orig1s000 CLINICAL PHARMACOLOGY AND BIOPHARMACEUTICS REVIEW(S) Page 1 of 45 Office of Clinical Pharmacology NDA Review Number
Documents
Clinical Pharmacology Biopharmaceutics Review(s)
Documents
Clinical Pharmacology/Biopharmaceutics Review
Documents
208078Orig1s000 - Food and Drug Administration€¦ · 208078Orig1s000 CLINICAL PHARMACOLOGY AND BIOPHARMACEUTICS REVIEW(S) 1 Office of Clinical Pharmacology Review Addendum (Erratum)
Documents
CENTER FOR DRUG EVALUATION AND RESEARCH APPLICATION … · The Office of Clinical Pharmacology (OCP) has reviewed the data submitted to the Clinical Pharmacology and Biopharmaceutics
Documents
Clinical Pharmacology and Biopharmaceutics Review(s)The Office of Clinical Pharmacology, Divisions of Clinical Pharmacology I and Pharmacometrics, have reviewed the information contained
Documents
21-045 Plan B Clinical Pharmacology Biopharmaceutics Review · Title: 21-045 Plan B Clinical Pharmacology Biopharmaceutics Review Created Date: 6/22/2001 11:08:10 AM
Documents
OFFICE OF CLINICAL PHARMACOLOGY AND …€¦ · Yuanchao (Derek) Zhang, Ph.D. Pharmacokinetics Reviewer, DPE III Office of Clinical Pharmacology and Biopharmaceutics. Concurrence:
Documents
CLINICAL PHARMACOLOGY REVIEW - accessdata.fda.gov€¦ · 2 1.1 Recommendations 3 1.2 Phase 4 Commitments 3 1.3 Summary of Important Clinical Pharmacology and Biopharmaceutics Findings
Documents
clinical pharmacology and biopharmaceutics review(s)
Documents
20-272S007 Biopharm Review Rwperdal Clinical Pharmacology … · 2009. 3. 31. · Title: 20-272S007 Biopharm Review Rwperdal Clinical Pharmacology Biopharmaceutics Review Part 3 Created
Documents
Clinical Pharmacology and Biopharmaceutics Review(s)...2.1 Clinical Pharmacology and Pharmacokinetics PF-05280014 is a proposed biosimilar to US-licensed Herceptin. US-licensed Herceptin
Documents
CLINICAL PHARMACOLOGY AND BIOPHARMACEUTICS REVIEW(S)€¦ · center for drug evaluation and research application number: 022406orig1s000 clinical pharmacology and biopharmaceutics
Documents
208547Orig1s000 - Food and Drug Administration · 208547Orig1s000 CLINICAL PHARMACOLOGY AND BIOPHARMACEUTICS REVIEW(S) NDA 208547 Review – Ga-68-DOTA-TATE 1 Clinical Pharmacology
Documents
Clinical Pharmacology & Biopharmaceutics
Documents
201820Orig1s000 - accessdata.fda.gov › ... › nda › 2012 › 201820Orig1s000C… · 201820Orig1s000 CLINICAL PHARMACOLOGY AND BIOPHARMACEUTICS REVIEW(S) OFFICE OF CLINICAL PHARMACOLOGY
Documents
11-522S030 Adderall Clinical Pharmacology …...11-522S030 Adderall Clinical Pharmacology Biopharmaceutics Review Created Date: 10/2/2003 10:36:12 AM ...
Documents
21-146 Atropine Sulfate Clinical Pharmacology Biopharmaceutics … · 2009. 4. 21. · Title: 21-146 Atropine Sulfate Clinical Pharmacology Biopharmaceutics Review Created Date: 10/11/2001
Documents